» Articles » PMID: 29728226

Radiomics in Radiooncology - Challenging the Medical Physicist

Overview
Journal Phys Med
Date 2018 May 6
PMID 29728226
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Noticing the fast growing translation of artificial intelligence (AI) technologies to medical image analysis this paper emphasizes the future role of the medical physicist in this evolving field. Specific challenges are addressed when implementing big data concepts with high-throughput image data processing like radiomics and machine learning in a radiooncology environment to support clinical decisions.

Methods: Based on the experience of our interdisciplinary radiomics working group, techniques for processing minable data, extracting radiomics features and associating this information with clinical, physical and biological data for the development of prediction models are described. A special emphasis was placed on the potential clinical significance of such an approach.

Results: Clinical studies demonstrate the role of radiomics analysis as an additional independent source of information with the potential to influence the radiooncology practice, i.e. to predict patient prognosis, treatment response and underlying genetic changes. Extending the radiomics approach to integrate imaging, clinical, genetic and dosimetric data ('panomics') challenges the medical physicist as member of the radiooncology team.

Conclusions: The new field of big data processing in radiooncology offers opportunities to support clinical decisions, to improve predicting treatment outcome and to stimulate fundamental research on radiation response both of tumor and normal tissue. The integration of physical data (e.g. treatment planning, dosimetric, image guidance data) demands an involvement of the medical physicist in the radiomics approach of radiooncology. To cope with this challenge national and international organizations for medical physics should organize more training opportunities in artificial intelligence technologies in radiooncology.

Citing Articles

Three-dimensional iodine mapping quantified by dual-energy CT for predicting programmed death-ligand 1 expression in invasive pulmonary adenocarcinoma.

Yamagata K, Yanagawa M, Hata A, Ogawa R, Kikuchi N, Doi S Sci Rep. 2024; 14(1):18310.

PMID: 39112802 PMC: 11306593. DOI: 10.1038/s41598-024-69470-9.


Research Trends and Evolution in Radiogenomics (2005-2023): Bibliometric Analysis.

Wang M, Peng Y, Wang Y, Luo D Interact J Med Res. 2024; 13:e51347.

PMID: 38980713 PMC: 11267093. DOI: 10.2196/51347.


The Radiation Therapist profession through the lens of new technology: A practice development paper based on the ESTRO Radiation Therapist Workshops.

Leech M, Abdalqader A, Alexander S, Anderson N, Barbosa B, Callens D Tech Innov Patient Support Radiat Oncol. 2024; 30:100243.

PMID: 38831996 PMC: 11145757. DOI: 10.1016/j.tipsro.2024.100243.


The impact of radiomics in the management of soft tissue sarcoma.

De Angelis R, Casale R, Coquelet N, Ikhlef S, Mokhtari A, Simoni P Discov Oncol. 2024; 15(1):62.

PMID: 38441726 PMC: 10914656. DOI: 10.1007/s12672-024-00908-2.


Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).

Wang Y, Lin W, Zhuang X, Wang X, He Y, Li L Oncol Rep. 2024; 51(3).

PMID: 38240090 PMC: 10828921. DOI: 10.3892/or.2024.8705.